For select risk-enhanced individuals at intermediate risk of coronary artery disease (CAD), researchers found a way to implement coronary artery calcium (CAC) scores and primary prevention statins ...

Canadian medical device innovator, Flosonics Medical, has secured $7.5 million CAD in venture debt financing from RBCx. The financing and specialized support will accelerate Flosonics Medical's ...

Flosonics Medical, has secured $7.5 million CAD in venture debt financing from RBCx. The financing and specialized support will accelerate Flosonics Medical’s mission to improve patient outcomes ...

SUDBURY, Ontario--(BUSINESS WIRE)-- Canadian medical device innovator, Flosonics Medical, has secured $7.5 million CAD in venture debt financing from RBCx. The financing and specialized support will ...

If the side effects seem life threatening or you think you’re having a medical emergency ... It’s possible for Mounjaro to cause some long-term side effects, such as digestive problems ...

Find out how we’re improving the quality of life for people with long term conditions and their carers. Our Declaration sets out the importance of person centred care for people with long term ...

AMA Update covers a range of health care topics affecting the lives of physicians, residents, medical students and patients ... Is that the same in terms of long COVID? Or are there still the symptoms ...

Their work was published in Nature ... CAD is the leading cause of death worldwide. While the symptoms and signs of coronary artery disease are noted in the advanced state of disease, most ...